NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine ... January 15, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by postregister. Read more Source: https://www.postregister.com/businessreport/technology/nrx-pharmaceuticals-nasdaq-nrxp-announces-70-000-patient-data-on-real-world-use-of-ketamine/article_f6fadda6-c9c1-5211-ba3d-bfab785f38e2.html
